Market Tracker

04/27 6:01pm ET

Regulus Therapeutics Inc (NASDAQ:RGLS)

During the Trading Day
14.59 -2.90 / -16.58%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
14.60 +0.01 / +0.07%
 
Volume: 3.3K

Today’s Trading

Previous close17.49
Today’s open17.07
Day’s range14.55 - 17.33
Volume2,564,771
Average volume (3 months)649,433
Market cap$883.5M
Dividend yield--
Data as of 3:59pm ET, 04/27/2015

Growth & Valuation

Earnings growth (last year)-163.27%
Earnings growth (this year)+21.58%
Earnings growth (next 5 years)--
Revenue growth (last year)-60.81%
P/E ratioNM
Price/Sales92.22
Price/Book6.48

Competitors

 Today’s
change
Today’s
% change
TKMRTekmira Pharmaceutic...-1.43-7.63%
EGRXEagle Pharmaceutical...-4.68-7.89%
OREXOrexigen Therapeutic...-0.41-5.57%
OMEROmeros Corp-1.18-4.85%
Data as of 3:59pm ET, 04/27/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$7.7M
Annual profit (last year)-$56.7M
Net profit margin-739.08%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, CFO, Director &
CAO
Kleanthis G. Xanthopoulos
Chief Scientific Officer
Neil W. Gibson
Corporate headquarters
San Diego, California

Forecasts